Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Assessing the Safety of Glucose-Lowering Drugs - A New Focus for the FDA.
Journal: The New England journal of medicine
Published: September 23, 2020
Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial.
Journal: The New England journal of medicine
Published: September 09, 2020
Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop.
Journal: Clinical pharmacology and therapeutics
Published: November 06, 2019
Showing 1-3 of 3
Last Updated: 09/26/2026